IBTA vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

IBTA

41.8
AI Score
VS
IBTA Wins

PACS

33.9
AI Score

Investment Advisor Scores

IBTA

42score
Recommendation
HOLD

PACS

34score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric IBTA PACS Winner
Forward P/E 24.6914 15.528 PACS
PEG Ratio 0 1.0347 Tie
Revenue Growth 3.3% 9.1% PACS
Earnings Growth -90.2% 51.6% PACS
Tradestie Score 41.8/100 33.9/100 IBTA
Profit Margin -3.2% 4.9% PACS
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

IBTA 1M: +18.7% · 3M: +86.3% PACS 1M: +15.7% · 3M: +1.4%

Current Technical Phase

IBTA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (14.3% over 20 days), RSI 73

RSI (14): 72.9 · Price: $48.90

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.1 · Price: $47.50

Fundamentals Snapshot

Metric IBTA PACS
Market Cap — —
Forward P/E 26.0 17.4
Trailing P/E — 27.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.8% 0.2%
Operating Margin 0.0% 0.1%
EPS -0.48 1.71
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IBTA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.